My bookmarksSign up free
Source

Council Decision (EU) 2026/1070 of 5 May 2026 on the position to be taken on behalf of the European Union within the CETA Joint Committee established under the Comprehensive Economic and Trade Agreement (CETA) between Canada, of the one part, and the European Union and its Member States, of the other part, as regards the inclusion of active pharmaceutical ingredients as medicinal products or drugs listed in paragraph 2 of Annex 1 to the Protocol on the mutual recognition of the compliance and enforcement programme regarding good manufacturing practices for pharmaceutical products

Council Decision (EU) 2026/1070 of 5 May 2026 on the position to be taken on behalf of the European Union within the CETA Joint Committee established under the Comprehensive Economic and Trade Agreement (CETA) between Canada, of the one part, and the European Union and its Member States, of the other part, as regards the inclusion of active pharmaceutical ingredients as medicinal products or drugs listed in paragraph 2 of Annex 1 to the Protocol on the mutual recognition of the compliance and enforcement programme regarding good manufacturing practices for pharmaceutical products

Decision (EU) 2026/1070 · Decision · 6 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The position to be taken on behalf of the Union within the CETA Joint Committee as regards the inclusion of active pharmaceutical ingredients as medicinal products or drugs listed in paragraph 2 of Annex 1 to the GMP Protocol to the Agreement shall be based on the draft decision of the CETA Joint Committee attached to this Decision.

Operational scope of medicinal products or drugs

Article 1

Open ↗

Paragraph 2 of Annex 1 to the Protocol on the mutual recognition of the compliance and enforcement programme regarding good manufacturing practices for pharmaceutical products shall be amended as follows: (a) at the end of the entry for point (f), the word ‘and’ shall be removed; (b) at the end of the entry for point (g), the full stop shall be replaced by ‘; and’; and, (c) after the entry for point (g), the following entry shall be added: ‘(h) active pharmaceutical ingredients.’.

Article 2

Open ↗

This Decision shall enter into force on the date of its adoption.

Legal status of the amendment

Article 2

Open ↗

Upon entry into force of this Decision, the amendment set out in Article 1 will become part of the Protocol. The Parties recognize that since the Agreement, including the Protocol, is provisionally applied, the amendment will also be provisionally applied until the Agreement enters into force.

Authentic texts

Article 3

Open ↗

This Decision is drawn up in duplicate in the Bulgarian, Croatian, Czech, Danish, Dutch, English, Estonian, Finnish, French, German, Greek, Hungarian, Italian, Latvian, Lithuanian, Maltese, Polish, Portuguese, Romanian, Slovak, Slovenian, Spanish and Swedish languages, each version being equally authentic.

Entry into force

Article 4

Open ↗

This Decision shall enter into force on the first day of the second month following the date Canada has provided to the European Union a written notification certifying that it has completed its internal requirements and procedures necessary for entry into force.

Other acts of the same type
Council Decision (CFSP) 2020/2143 of 17 December 2020 amending Decision 2014/512/CFSP concerning restrictive measures in view of Russia’s actions destabilising the situation in UkraineCouncil Implementing Decision (CFSP) 2020/2144 of 17 December 2020 implementing Decision 2010/788/CFSP concerning restrictive measures against the Democratic Republic of the CongoCommission Decision (EU) 2020/2166 of 17 December 2020 on the determination of the Member States’ auction shares during the period 2021-2030 of the EU Emissions Trading System (notified under document C(2020) 8945) (Text with EEA relevance)Commission Implementing Decision (EU) 2020/2168 of 17 December 2020 on the compliance of the joint proposal submitted by the Member States concerned for the extension of the North Sea-Baltic rail freight corridor with Article 5 of Regulation (EU) No 913/2010 of the European Parliament and of the Council concerning a European rail network for competitive freight (notified under document C(2020) 8919) (Only the Czech, Dutch, Estonian, French, German, Latvian, Lithuanian and Polish texts are authentic)Council Decision (EU) 2020/2186 of 17 December 2020 on the position to be taken on behalf of the European Union within the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community as regards practical working arrangements relating to the exercise of the rights of Union representativesCommission Implementing Decision (EU) 2020/2200 of 17 December 2020 on the extension of the periods for the collection of statements of support for certain European citizens’ initiatives pursuant to Regulation (EU) 2020/1042 of the European Parliament and of the Council (notified under document C(2020) 9226) (Only the English text is authentic)Council Decision (EU) 2021/1 of 17 December 2020 on the position to be taken on behalf of the European Union within the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community as regards agricultural subsidiesCouncil Decision (EU) 2021/2 of 17 December 2020 on the position to be taken on behalf of the European Union within the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community as regards the adoption of a decision to amend the Protocol on Ireland/Northern IrelandCouncil Decision (EU) 2021/12 of 17 December 2020 on the position to be taken on behalf of the European Union within the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community as regards the determination of goods not at riskCommission Implementing Decision (EU) 2020/2113 of 16 December 2020 amending Annex I to Decision 2004/3/EC authorising, in respect of the marketing of seed potatoes in all or part of the territory of certain Member States, more stringent measures against certain diseases than are provided for in Annexes I and II to Council Directive 2002/56/EC, as regards the entry for the United Kingdom (notified under document C(2020) 9306) (Text with EEA relevance)Commission Implementing Decision (EU) 2020/2125 of 16 December 2020 recognising the Government of Nunavut as a body that is authorised to issue documents attesting compliance with Regulation (EC) No 1007/2009 of the European Parliament and of the Council for placing seal products on the Union marketCommission Implementing Decision (EU) 2020/2126 of 16 December 2020 on setting out the annual emission allocations of the Member States for the period from 2021 to 2030 pursuant to Regulation (EU) 2018/842 of the European Parliament and of the Council (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next